| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 96361 |
Intravenous infusion, hydration; each additional hour |
13,976 |
9,675 |
$3.35M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,037 |
17,325 |
$1.81M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,898 |
17,933 |
$1.50M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13,571 |
12,643 |
$1.50M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
17,362 |
15,164 |
$1.08M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,671 |
5,391 |
$851K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,296 |
4,806 |
$662K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
13,840 |
9,548 |
$658K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,020 |
3,376 |
$407K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,339 |
1,265 |
$336K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,905 |
1,859 |
$313K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,778 |
2,972 |
$311K |
| 59025 |
Fetal non-stress test |
2,286 |
1,807 |
$310K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
9,072 |
7,765 |
$263K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,276 |
3,567 |
$249K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,473 |
1,533 |
$246K |
| 92558 |
|
2,527 |
2,456 |
$222K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,472 |
1,550 |
$205K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,269 |
1,205 |
$194K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,407 |
2,300 |
$189K |
| 80053 |
Comprehensive metabolic panel |
36,377 |
28,102 |
$135K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
597 |
584 |
$123K |
| 76830 |
Ultrasound, transvaginal |
1,721 |
1,666 |
$122K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,542 |
830 |
$111K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,970 |
1,909 |
$91K |
| 93971 |
|
1,195 |
1,133 |
$90K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
8,100 |
7,067 |
$87K |
| G0378 |
Hospital observation service, per hour |
4,104 |
3,193 |
$77K |
| 71046 |
Radiologic examination, chest; 2 views |
5,526 |
5,252 |
$69K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,577 |
1,701 |
$68K |
| 76642 |
|
695 |
682 |
$63K |
| 84484 |
|
13,866 |
9,401 |
$50K |
| 70496 |
|
352 |
337 |
$47K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
944 |
916 |
$44K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,202 |
2,309 |
$42K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,384 |
517 |
$41K |
| 76801 |
|
847 |
757 |
$28K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
260 |
252 |
$28K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,777 |
6,448 |
$26K |
| 97161 |
|
1,037 |
864 |
$26K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
17,964 |
14,378 |
$24K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,014 |
921 |
$21K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
94 |
92 |
$21K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16,715 |
13,795 |
$19K |
| 87040 |
|
3,247 |
1,620 |
$19K |
| 73610 |
|
1,476 |
1,380 |
$18K |
| 73630 |
|
1,357 |
1,310 |
$18K |
| 93017 |
|
246 |
242 |
$17K |
| 83605 |
|
3,976 |
3,191 |
$17K |
| 87486 |
|
1,131 |
1,081 |
$16K |
| 73564 |
|
1,502 |
1,432 |
$15K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,900 |
1,796 |
$14K |
| 10060 |
|
57 |
50 |
$12K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
67 |
67 |
$12K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,127 |
1,077 |
$11K |
| 73030 |
|
1,223 |
1,159 |
$11K |
| 80047 |
|
3,727 |
3,206 |
$10K |
| 97165 |
|
386 |
373 |
$10K |
| 73130 |
|
851 |
818 |
$10K |
| 85379 |
|
2,117 |
2,028 |
$10K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
713 |
438 |
$10K |
| 73110 |
|
758 |
712 |
$9K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,156 |
1,090 |
$9K |
| 87581 |
|
1,131 |
1,081 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
16,897 |
12,453 |
$9K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
28 |
27 |
$9K |
| 93975 |
|
130 |
124 |
$8K |
| 76536 |
|
132 |
129 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
25,671 |
21,163 |
$8K |
| 83880 |
|
2,048 |
1,859 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
10,861 |
8,096 |
$7K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
133 |
84 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
11,866 |
7,926 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
122 |
116 |
$7K |
| 76770 |
|
92 |
89 |
$7K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
88 |
84 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14,125 |
10,102 |
$6K |
| 73140 |
|
310 |
305 |
$6K |
| 70498 |
|
297 |
284 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
649 |
585 |
$5K |
| 93321 |
|
37 |
37 |
$5K |
| 97535 |
Self-care/home management training, each 15 minutes |
417 |
318 |
$5K |
| 73502 |
|
503 |
490 |
$5K |
| 96367 |
|
66 |
52 |
$5K |
| 85027 |
|
22,979 |
15,865 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
590 |
558 |
$4K |
| 77066 |
Tomosynthesis, mammo |
154 |
151 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,858 |
7,219 |
$4K |
| 88720 |
|
1,963 |
1,889 |
$4K |
| 71250 |
|
86 |
84 |
$3K |
| 97116 |
|
328 |
228 |
$3K |
| 90715 |
|
216 |
211 |
$3K |
| 72100 |
|
450 |
437 |
$3K |
| 80069 |
|
1,764 |
783 |
$3K |
| 77065 |
Tomosynthesis, mammo |
101 |
90 |
$3K |
| 93970 |
|
31 |
31 |
$3K |
| 96376 |
|
7,562 |
4,538 |
$3K |
| 74018 |
|
255 |
223 |
$3K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
516 |
497 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,625 |
4,883 |
$3K |
| 80306 |
|
1,692 |
1,599 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
15 |
15 |
$2K |
| 83690 |
|
11,617 |
9,461 |
$2K |
| 81001 |
|
16,878 |
14,816 |
$2K |
| 84703 |
|
9,687 |
8,891 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,291 |
5,701 |
$2K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
3,452 |
3,265 |
$2K |
| 73080 |
|
131 |
124 |
$2K |
| 93325 |
|
136 |
135 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
52 |
51 |
$2K |
| 86850 |
|
1,151 |
1,104 |
$1K |
| 83735 |
|
3,818 |
2,713 |
$1K |
| 86900 |
|
2,020 |
1,889 |
$1K |
| 85014 |
|
5,283 |
4,256 |
$1K |
| 84702 |
|
3,439 |
2,294 |
$1K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,638 |
2,540 |
$1K |
| 87510 |
|
250 |
241 |
$1K |
| 80061 |
Lipid panel |
992 |
949 |
$1K |
| 72110 |
|
44 |
44 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
80 |
78 |
$1K |
| 70486 |
|
57 |
55 |
$1K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
69 |
52 |
$983.81 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
294 |
280 |
$971.16 |
| 70544 |
|
12 |
12 |
$924.86 |
| 87186 |
|
2,326 |
1,980 |
$831.34 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$789.67 |
| 86140 |
|
1,676 |
1,497 |
$727.36 |
| 86901 |
|
2,008 |
1,888 |
$696.84 |
| 82948 |
|
3,895 |
1,749 |
$684.25 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,749 |
1,572 |
$627.19 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,449 |
1,190 |
$593.83 |
| 81003 |
|
6,685 |
5,433 |
$580.02 |
| 87660 |
|
250 |
241 |
$568.10 |
| 77080 |
|
12 |
12 |
$551.90 |
| 84439 |
|
969 |
908 |
$531.90 |
| 85610 |
|
8,102 |
4,696 |
$505.00 |
| 82803 |
|
1,111 |
991 |
$481.38 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
140 |
135 |
$416.47 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,049 |
1,197 |
$411.12 |
| 97162 |
|
13 |
13 |
$352.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,510 |
1,372 |
$345.74 |
| 73590 |
|
55 |
51 |
$335.42 |
| 93351 |
|
37 |
37 |
$334.20 |
| 82565 |
|
872 |
810 |
$328.53 |
| 87081 |
|
978 |
933 |
$326.92 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
409 |
387 |
$320.46 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
814 |
613 |
$319.84 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,713 |
2,388 |
$312.29 |
| 82607 |
|
281 |
269 |
$311.39 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
590 |
559 |
$300.87 |
| 76377 |
|
232 |
206 |
$281.53 |
| 85652 |
|
1,297 |
1,174 |
$279.42 |
| 87070 |
|
993 |
901 |
$277.39 |
| 71101 |
|
26 |
25 |
$260.29 |
| 90686 |
|
34 |
34 |
$241.46 |
| J1644 |
Injection, heparin sodium, per 1000 units |
5,582 |
2,144 |
$223.11 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,383 |
6,302 |
$223.04 |
| J2060 |
Injection, lorazepam, 2 mg |
3,401 |
2,654 |
$208.25 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
877 |
846 |
$207.69 |
| 82550 |
|
627 |
416 |
$197.95 |
| 80076 |
|
89 |
85 |
$183.73 |
| 36591 |
|
230 |
110 |
$153.93 |
| 87205 |
|
1,030 |
935 |
$142.90 |
| 72040 |
|
12 |
12 |
$132.89 |
| 83550 |
|
101 |
98 |
$124.84 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,981 |
3,828 |
$117.70 |
| 83874 |
|
12 |
12 |
$116.82 |
| 83540 |
|
102 |
99 |
$110.20 |
| 73090 |
|
12 |
12 |
$96.84 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
10,138 |
7,068 |
$92.80 |
| C9113 |
Injection, pantoprazole sodium, per vial |
849 |
548 |
$86.66 |
| 74022 |
|
12 |
12 |
$80.21 |
| 87088 |
|
681 |
633 |
$69.54 |
| 82248 |
|
20 |
12 |
$67.61 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
7,063 |
4,673 |
$61.47 |
| G0008 |
Administration of influenza virus vaccine |
150 |
147 |
$60.57 |
| 87147 |
|
572 |
503 |
$58.03 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,052 |
2,661 |
$51.56 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
306 |
300 |
$47.60 |
| 87077 |
|
486 |
329 |
$43.07 |
| 87480 |
|
250 |
241 |
$38.48 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,340 |
1,836 |
$35.15 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,841 |
1,520 |
$29.40 |
| J1815 |
Injection, insulin, per 5 units |
2,078 |
683 |
$20.26 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
660 |
441 |
$19.50 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
424 |
346 |
$17.97 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,779 |
4,241 |
$16.10 |
| 99152 |
|
146 |
123 |
$15.93 |
| 88304 |
|
154 |
147 |
$15.68 |
| 84100 |
|
24 |
18 |
$14.25 |
| 88342 |
|
30 |
26 |
$13.77 |
| A9270 |
Non-covered item or service |
10,361 |
2,046 |
$13.41 |
| 90662 |
|
27 |
27 |
$12.10 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,104 |
792 |
$11.61 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
68 |
66 |
$8.70 |
| 84550 |
|
40 |
37 |
$8.57 |
| 82553 |
|
27 |
15 |
$8.36 |
| 82728 |
|
14 |
13 |
$7.99 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,096 |
828 |
$7.04 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,045 |
2,409 |
$6.46 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,159 |
2,696 |
$4.78 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
374 |
289 |
$4.30 |
| 85018 |
|
63 |
39 |
$3.86 |
| 82570 |
|
50 |
45 |
$3.49 |
| C1769 |
Guide wire |
1,401 |
676 |
$2.75 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
91 |
60 |
$0.12 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
950 |
892 |
$0.11 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
671 |
290 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
128 |
125 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,246 |
538 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
51 |
27 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
81 |
65 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
53 |
51 |
$0.00 |
| 82010 |
|
26 |
25 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
42 |
39 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
133 |
113 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
46 |
24 |
$0.00 |
| 84156 |
|
15 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
143 |
120 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
45 |
42 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
15 |
12 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
130 |
128 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
68 |
68 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
305 |
269 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
124 |
106 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
284 |
265 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
51 |
51 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
43 |
40 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
30 |
19 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
24 |
12 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
16 |
13 |
$0.00 |
| 82746 |
|
27 |
27 |
$0.00 |